Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan dose-ranging Phase 2b study in symptomatic endometriosis
2013-004768-72Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vilaprisan in endometriosis (3 arms), sponsored by Bayer. Primary endpoint: Change in 7-day mean worst pain from baseline to Month 3. Started Apr 2018; status: completed.
02
Drugs
vilaprisan
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2013-004768-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004768-72.